Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239–42.
Article
CAS
Google Scholar
Siemieniuk RA, Bartoszko JJ, Ge L, Zeraatkar D, Izcovich A, Kum E, Pardo-Hernandez H, Qasim A, Martinez JPD, Rochwerg B. Drug treatments for covid-19: living systematic review and network meta-analysis. BMJ. 2020;370:56.
Google Scholar
Hoenigl M. Invasive fungal disease complicating coronavirus disease 2019: when it rains, it spores. Clin Infect Dis. 2020.
Chen W, Yin C, Zhong M, Hu B, Gao X, Zhang K, Liu Y, Zhuang G. Incidence, risk factors, and outcomes of patients with COVID‑19‑associated pulmonary aspergillosis (CAPA) in intensive care units: a systematic review and meta-analysis of 29 cohort studies. 2021.
Chong WH, Neu KP. The incidence, diagnosis, and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): a systematic review. J Hosp Infect. 2021.
Kariyawasam RM, Dingle TC, Kula BE, Sligl WI, Schwartz IS. COVID-19 associated pulmonary aspergillosis: systematic review and patient-level meta-analysis. medRxiv. 2021.
Kula BE, Clancy CJ, Nguyen MH, Schwartz IS. Invasive mould disease in fatal covid-19: a systematic review of autopsies. Lancet Microbe. 2021.
Mitaka H, Kuno T, Takagi H, Patrawalla P. Incidence and mortality of COVID‐19‐associated pulmonary aspergillosis: a systematic review and meta‐analysis. Mycoses. 2021.
Chong WH, Saha BK, Neu KP. Comparing the clinical characteristics and outcomes of COVID-19-associate pulmonary aspergillosis (CAPA): a systematic review and meta-analysis. Infection. 2021:1–14.
Fekkar A, Neofytos D, Nguyen M-H, Clancy CJ, Kontoyiannis DP, Lamoth F. COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it? Clin Microbiol Infect. 2021.
Thompson GR III, Young J-AH. Aspergillus infections. N Engl J Med. 2021;385(16):1496–509.
Article
CAS
Google Scholar
van Paassen J, Vos JS, Hoekstra EM, Neumann KM, Boot PC, Arbous SM. Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes. Crit Care. 2020;24(1):1–22.
Article
Google Scholar
Cheng B, Ma J, Yang Y, Shao T, Zhao B, Zeng L. Systemic corticosteroid administration in coronavirus disease 2019 outcomes: an umbrella meta-analysis incorporating both mild and pulmonary fibrosis-manifested severe disease. Front Pharmacol. 2021;12:1193.
Google Scholar
Group RC. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021;384(8):693–704.
Article
Google Scholar
Sterne JA, Murthy S, Diaz JV, Slutsky AS, Villar J, Angus DC, Annane D, Azevedo LCP, Berwanger O, Cavalcanti AB. Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis. JAMA. 2020;324(13):1330–41.
Article
CAS
Google Scholar
COVID-19 Treatment Guidelines Panel. Coronavirus disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. https://www.covid19treatmentguidelines.nih.gov/.
European Medicines Agency (EMA) endorses use of dexamethasone in COVID-19 patients on oxygen or mechanical ventilation. https://www.ema.europa.eu/en/documents/press-release/ema-endorses-use-dexamethasone-covid-19-patients-oxygen-mechanical-ventilation_en.pdf.
Kluge S, Janssens U, Welte T, Weber-Carstens S, Schälte G, Spinner CD, Malin JJ, Gastmeier P, Langer F, Wepler M. S2k-Leitlinie–Empfehlungen zur stationären Therapie von Patienten mit COVID-19. Pneumologie. 2021;75(02):88–112.
Article
CAS
Google Scholar
Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet. 2020;395(10223):473–5.
Article
CAS
Google Scholar
Lamoth F, Lewis RE, Walsh TJ, Kontoyiannis DP. Navigating the uncertainties of COVID-19 associated aspergillosis (CAPA): a comparison with influenza associated aspergillosis (IAPA). J Infect Dis. 2021.
Bahl A, Johnson S, Chen N-W. Timing of corticosteroids impacts mortality in hospitalized COVID-19 patients. Intern Emerg Med. 2021:1–11.
Bretagne S, Sitbon K, Botterel F, Dellière S, Letscher-Bru V, Chouaki T, Bellanger A-P, Bonnal C, Fekkar A, Persat F. COVID-19-associated pulmonary aspergillosis, fungemia, and pneumocystosis in the intensive care unit: a retrospective multicenter observational cohort during the first French pandemic wave. Microbiol Spectr. 2021;9(2):e01138-e11121.
Article
Google Scholar
Dewi IM, Janssen NA, Rosati D, Bruno M, Netea MG, Brüggemann RJ, Verweij PE, van de Veerdonk FL. Invasive pulmonary aspergillosis associated with viral pneumonitis. Curr Opin Microbiol. 2021;62:21–7.
Article
CAS
Google Scholar
Verweij PE, Brüggemann RJ, Azoulay E, Bassetti M, Blot S, Buil JB, Calandra T, Chiller T, Clancy CJ, Cornely OA. Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis. Intensive Care Med. 2021:1–16.
Koehler P, Bassetti M, Chakrabarti A, Chen SC, Colombo AL, Hoenigl M, Klimko N, Lass-Flörl C, Oladele RO, Vinh DC. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis. 2020.
Verweij PE, Gangneux J-P, Bassetti M, Brüggemann RJ, Cornely OA, Koehler P, Lass-Flörl C, van de Veerdonk FL, Chakrabarti A, Hoenigl M. Diagnosing COVID-19-associated pulmonary aspergillosis. Lancet Microbe. 2020;1(2):e53–5.
Article
CAS
Google Scholar
Donnelly JP, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, Verweij PE, Clancy CJ, Wingard JR, Lockhart SR, Groll AH. Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis. 2020;71(6):1367–76.
Article
Google Scholar
White PL, Dhillon R, Cordey A, Hughes H, Faggian F, Soni S, Pandey M, Whitaker H, May A, Morgan M. A national strategy to diagnose coronavirus disease 2019—associated invasive fungal disease in the intensive care unit. Clin Infect Dis. 2020.
Dellière S, Dudoignon E, Fodil S, Voicu S, Collet M, Oillic P-A, Salmona M, Dépret F, Ghelfenstein-Ferreira T, Plaud B. Risk factors associated with COVID-19-associated pulmonary aspergillosis in ICU patients: a French multicentric retrospective cohort. Clin Microbiol Infect. 2021; 27(5):790.e791–790.e795.
Permpalung N, Chiang TP-Y, Massie AB, Zhang SX, Avery RK, Nematollahi S, Ostrander D, Segev DL, Marr KA. COVID-19 associated pulmonary aspergillosis in mechanically ventilated patients. Clin Infect Dis. 2021.
Fekkar A, Lampros A, Mayaux J, Poignon C, Demeret S, Constantin J-M, Marcelin A-G, Monsel A, Luyt C-E, Blaize M. Occurrence of invasive pulmonary fungal infections in patients with severe COVID-19 admitted to the ICU. Am J Respir Crit Care Med. 2021;203(3):307–17.
Article
CAS
Google Scholar
Bartoletti M, Pascale R, Cricca M, Rinaldi M, Maccaro A, Bussini L, Fornaro G, Tonetti T, Pizzilli G, Francalanci E et al. Epidemiology of invasive pulmonary aspergillosis among intubated patients with COVID-19: a prospective study. Clin Infect Dis. 2020.
Montrucchio G, Lupia T, Lombardo D, Stroffolini G, Corcione S, De Rosa F, Brazzi L. Risk factors for invasive aspergillosis in ICU patients with COVID-19: current insights and new key elements. Ann Intensive Care. 2021;11(1):1–11.
Article
Google Scholar
Schröder C, Peña Diaz LA, Rohde AM, Piening B, Aghdassi SJS, Pilarski G, Thoma N, Gastmeier P, Leistner R, Behnke M. Lean back and wait for the alarm? Testing an automated alarm system for nosocomial outbreaks to provide support for infection control professionals. PLoS ONE. 2020;15(1):e0227955.
Article
Google Scholar
Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(5):309–32.
Article
Google Scholar
Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307(23):2526–33.
PubMed
Google Scholar
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.
Article
CAS
Google Scholar
Thygesen SK, Christiansen CF, Christensen S, Lash TL, Sørensen HT. The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients. BMC Med Res Methodol. 2011;11(1):1–6.
Article
Google Scholar
Angus DC, Derde L, Al-Beidh F, Annane D, Arabi Y, Beane A, van Bentum-Puijk W, Berry L, Bhimani Z, Bonten M. Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial. JAMA. 2020;324(13):1317–29.
Article
CAS
Google Scholar
Gangneux J-P, Dannaoui E, Fekkar A, Luyt C-E, Botterel F, De Prost N, Tadié J-M, Reizine F, Houzé S, Timsit J-F. Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study. Lancet Respir Med. 2021.
Xu J, Yang X, Lv Z, Zhou T, Liu H, Zou X, Cao F, Zhang L, Liu B, Chen W. Risk factors for invasive aspergillosis in patients admitted to the intensive care unit with coronavirus disease 2019: a multicenter retrospective study. Front Med. 2021, 8.
Janssen NAF, Nyga R, Vanderbeke L, Jacobs C, Ergün M, Buil JB, van Dijk K, Altenburg J, Bouman CSC, van der Spoel HI, et al. Multinational observational cohort study of COVID-19-associated pulmonary aspergillosis(1). Emerg Infect Dis. 2021;27(11):2892–8.
Article
CAS
Google Scholar
Janssen NA, Nyga R, Vanderbeke L, Jacobs C, Ergün M, Buil JB, van Dijk K, Altenburg J, Bouman CS, van der Spoel HI. Multinational observational cohort study of COVID-19-associated pulmonary aspergillosis. Emerg Infect Dis. 2021;27(11):2892.
Article
CAS
Google Scholar
Safdar N, Crnich CJ, Maki DG. The pathogenesis of ventilator-associated pneumonia: its relevance to developing effective strategies for prevention. Respir Care. 2005;50(6):725–41.
PubMed
Google Scholar
Maes M, Higginson E, Pereira-Dias J, Curran MD, Parmar S, Khokhar F, Cuchet-Lourenço D, Lux J, Sharma-Hajela S, Ravenhill B, et al. Ventilator-associated pneumonia in critically ill patients with COVID-19. Crit Care. 2021;25(1):25.
Article
Google Scholar
Macedo A, Gonçalves N, Febra C. COVID-19 fatality rates in hospitalized patients: systematic review and meta-analysis. Ann Epidemiol. 2021.